Sort
51,593 grants matching “hepatitis”
Nuclear Receptor Signaling Pathways in Atherogenesis
$385,000Peter J Tontonoz · University Of California Los Angeles · R01 · FY2016 · HL
Attacking the Global Problem of Antimicrobial Resistance
$385,000Linda D Hazlett · Wayne State University · R01 · FY2020 · EY
Orphan Nuclear Receptors in Lipid Metabolism and Inflammation
$385,000Peter J Tontonoz · University Of California Los Angeles · P01 · FY2015 · HL
Post-Translational Regulation of Lipid Metabolism
$385,000Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2018 · HL
Symptom burden in End-Stage Liver Disease patient-caregiver dyads
$385,000Lissi Hansen · Oregon Health & Science University · R01 · FY2019 · NR
Molecular Biology of Bile Acid Synthesis
$385,000John Y. Chiang · Northeast Ohio Medical University · R01 · FY2010 · DK
Cell-specific and multifunctional drug formulations for in vivo delivery
$385,000Yizhou Dong · Ohio State University · R35 · FY2017 · GM
Symptom burden in End-Stage Liver Disease patient-caregiver dyads
$385,000Lissi Hansen · Oregon Health & Science University · R01 · FY2020 · NR
The role of PON2 and PON3 proteins in atherosclerosis
$385,000Srinivasa Reddy · University Of California Los Angeles · R01 · FY2017 · HL
The role of PON2 and PON3 proteins in atherosclerosis
$385,000Srinivasa Reddy · University Of California Los Angeles · R01 · FY2016 · HL
Transcriptional control of microRNAs in lipid metabolism and atherosclerosis
$385,000Thomas A Vallim · University Of California Los Angeles · R01 · FY2018 · HL
ERalpha and the metabolic syndrome
$385,000Andrea L Hevener · University Of California Los Angeles · R01 · FY2011 · DK
Adiponectin Actions on the Monocyte to Reduce Atherosclerosis
$385,000Rajendra K Tangirala · University Of California Los Angeles · R01 · FY2011 · HL
Heat Shock Protein Synthesis Inhibitor Treatment of Hepatitis C Viral Infection
$385,000Samuel Wheeler French · University Of California Los Angeles · R01 · FY2011 · DK
Cell-specific and multifunctional drug formulations for in vivo delivery
$384,998Yizhou Dong · Ohio State University · R35 · FY2018 · GM
Genetic Reconstitution for Phenylketonuria
$384,989Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · DK
Mechanisms of Diabetic Hyperphagia and Insulin Resistance
$384,986Michael W Schwartz · University Of Washington · R01 · FY2009 · DK
Mechanisms of Diabetic Hyperphagia and Insulin Resistance
$384,986Michael W Schwartz · University Of Washington · R01 · FY2008 · DK
Reprogramming of liver cell fate by Hippo signaling
$384,975Fernando Camargo · Boston Children'S Hospital · R01 · FY2016 · DK
Reprogramming of liver cell fate by Hippo signaling
$384,975Fernando Camargo · Boston Children'S Hospital · R01 · FY2017 · DK
Stem Cell Therapy and Postinfarction LV Remodeling
$384,963Jianyi Zhang · University Of Minnesota · R01 · FY2007 · HL
Novel therapy for preeclampsia
$384,958Mohammad Nasir Uddin · Emergent Biotechnologies Llc · R43 · FY2022 · HD
Herb-Opioid Interactions
$384,904Fred Hutchinson Cancer Research Center · R01 · FY2003 · AT
Present Homologous and Heterologous Antigen with Hepatitis E Virus
$384,896R. Holland Cheng · University Of California At Davis · R56 · FY2012 · AI
Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease
$384,879In-Woo Park · University Of North Texas Hlth Sci Ctr · R01 · FY2014 · DK